Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-05
2011-10-11
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S006120, C436S501000
Reexamination Certificate
active
08034574
ABSTRACT:
The present invention provides a screening tool and screening method for obtaining a substance useful as a prophylactic and/or therapeutic drug for diseases associated with 5-HT production/secretion abnormalities, including digestive organ diseases, and a prophylactic and/or therapeutic drug for diseases associated with 5-HT production/secretion abnormalities, including digestive organ diseases. Examples of digestive organ diseases in the present invention include constipation type irritable bowel syndrome, functional dyspepsia, constipation, diarrhea type irritable bowel syndrome, diarrhea and vomiting.
REFERENCES:
patent: 2006-199647 (2006-08-01), None
patent: WO 2005/089206 (2005-09-01), None
patent: WO 2005089206 (2005-09-01), None
patent: WO 2007/073505 (2007-06-01), None
patent: WO 2007/073505 (2007-06-01), None
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 491-495.
Bandell et al. (2004). Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 41:849-857.
Alexander Stokes, et al., “TRPA1 is a Substrate for de-ubiquitination by the Tumor Suppressor CYLD”, Cellular Signalling, vol. 18, No. Oct. 10, 2006, pp. 1584-1594.
Hiroshi Watanabe, et al., “Central Effects of Cinnamaldehyde”, Journal of the Pharmaceutical Society of Japan, vol. 104, No. 10, 1984, pp. 1095-1100.
Diana M. Bautista, et al., “TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents”, Cell, vol. 124, No. 6, Mar. 24, 2006, pp. 1269-1282.
Peter Holzer, “Gastrointestinal Pain in Functional Bowel Disorders: Sensory Neurons as Novel Drug Targets”, Expert Opinion on Therapeutic Targets, vol. 8, No. 2, Apr. 2004, pp. 107-123 with cover page.
Sven-Eric Jordt, et al., “Mustard Oils and Cannabinoids excite sensory nerve fibres through the TRP Channel ANKTM1”, Nature, Letters to Nature, vol. 427, Jan. 15, 2004, pp. 260-265.
Gina M. Story, et al., “ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, is Activated by Cold Temperatures”, Cell, vol. 112, Mar. 21, 2003, pp. 819-829.
William L. Hasler, et al., “Irritable Bowel Syndrome Pathophysiology” Textbook of Gastroenterology, 4thEdition, Chapter 86, ISBN 0-7817-2861-4, 7 pages.
Diana M. Bautista, et al., “Pungent products from garlic activate the sensory ion channel TRPA1”, Proceedings of the National Academy of Sciences of USA, vol. 102, No. 34, XP009125805, Aug. 23, 2005, pp. 12248-12252.
Barbara Namer, et al., “TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol” , NeuroReport, vol. 16, No. 9, XP 009091531, Jun. 21, 2005, pp. 955-959.
Aerssens Jeroen, et al., “Altered expression of TRP, Ca2+ and K+ channels in vagal visceral afferents in a post-infectious model of irritable bowel syndrome (IBS)”, Biosis, XP-002433340, Apr. 1, 2006, 1 page.
Lin Jiahui, et al., “Properties of Human TRPa1, a Mechanosensitive Channel and Putative Nociceptor” AGA Abstracts, Gastroenterology, vol. 130, No. 4, Suppl. 2, XP 009086552, Apr. 2006, p. A225.
Peter Holzer, et al. “Stimulation of the Brain-Gut Axis by Intracolonic Mustard Oil is Enhanced in Mice with low-Grade Colitis”, AGA Abstracts, Gastroenterology, vol. 132, No. 4, Suppl. 2, XP009125772, Apr. 2007, p. A720.
Angelica Penuelas, et al., “Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine”, European Journal of Pharmacology, vol. 576, No. 1-3, XP0022307550, Dec. 8, 2007, pp. 143-150.
S. Hayashi, et al., “Impairment by activation of TRPA1 of gastric epithelial restitution in a wound model using RGM1 cell monolayer”, Inflammopharmacology, vol. 15, No. 3, XP009125779, Oct. 1, 2007, pp. 218-222.
João B. Calixto, et al., “Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions”, Pharmacology and Therapeutics, vol. 106, No. 2, XP004870342, May 1, 2005, pp. 179-208.
Katsura Nozawa, et al., “TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells”, Proceedings of the National Academy of Sciences of the United States of America, vol. 106, No. 9, XP002555859, pp. 3408-3413, 2009.
Keiichi Nagata et al., “Nociceptor and Hair Cell Transducer Properties of TRPA1, a Channel for Pain and Hearing”, The Journal of Neuroscience, Apr. 20, 2005, vol. 25 (16), pp. 4052-4061.
Doihara Hitoshi
Kojima Ryosuke
Nozawa Katsura
Shoda Eri
Astellas Pharma Inc.
Lockard Jon M
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Saoud Christine J
LandOfFree
Screening method for prokinetic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for prokinetic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for prokinetic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268247